UCM — USCOM Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- AU$3.01m
- AU$4.30m
- AU$2.61m
Annual income statement for USCOM, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.98 | 2.62 | 2.72 | 3.77 | 2.61 |
Cost of Revenue | |||||
Gross Profit | 3.49 | 2.28 | 2.3 | 3.16 | 2.26 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5.16 | 4.98 | 5.58 | 6.1 | 6.28 |
Operating Profit | -1.18 | -2.36 | -2.86 | -2.33 | -3.66 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.882 | -1.94 | -2.56 | -2.03 | -3.25 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.924 | -1.97 | -2.59 | -2.07 | -3.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.924 | -1.97 | -2.59 | -2.07 | -3.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.924 | -1.97 | -2.59 | -2.07 | -3.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.007 | -0.012 | -0.015 | -0.012 | -0.017 |